We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.
- Authors
Burkard, Mark E; Wisinski, Kari B; Njiaju, Uchenna O; Donohue, Sarahmaria; Hegeman, Robert; Stella, Amy; Mansky, Patrick; Shah, Varsha; Goggins, Timothy; Qamar, Rubina; Dietrich, Leah; Kim, Kyungmann; Traynor, Anne M; Tevaarwerk, Amye J
- Abstract
Dose-dense therapies have had a major effect on reducing toxicity and improving outcomes in breast cancer. A combination of TC every 3 weeks has emerged as a common chemotherapy regimen used for treatment of node-negative or lower-risk node-positive breast cancer. We tested whether it is feasible to deliver TC on a dose-dense schedule, with therapy completed within 10 weeks.
- Publication
Clinical breast cancer, 2014, Vol 14, Issue 3, p205
- ISSN
1938-0666
- Publication type
Journal Article
- DOI
10.1016/j.clbc.2013.10.018